Gabriela C.

Gabriela C. has had extensive work experience in the biopharmaceutical and biotechnology industries. Gabriela started their career as a Research Associate at Chiron Corporation in 2006, where they worked on the development of an ELISA-based immunodiagnostic assay for the detection of HIV. Gabriela also provided cross-departmental support for Novartis Manufacturing and contributed to scientific publications.

After their time at Chiron Corporation, Gabriela worked at Novartis as a Research Associate, focusing on the development and optimization of immunoassays for HIV detection. Gabriela also supported the development of the VITROS HBsAg ES Assay and collaborated with the joint business partner.

Gabriela then joined Precision For Medicine as a Senior Research Associate in the Bioanalytical Group within the Immunology Group. Their responsibilities included the development, qualification, and validation of immunoassays for various biological products. Gabriela also performed quality checks for scientific data and authored technical documents.

Gabriela later worked at Translational Biocience as a Senior Research Associate, where they optimized a novel PD biomarker assay using the Simoa technology. Gabriela conducted routine analysis of clinical samples for protein biomarker detection.

Gabriela then joined Adverum Biotechnologies as a Senior Researcher, supporting the Assay Development team in the development and performance of quantitative assays. Gabriela focused on MSD quantitative assays and LBA assays for Adverum's proprietary vector capsid.

Their most recent role is as an Associate Scientist at Annexon Biosciences, a clinical-stage biopharmaceutical company. Gabriela is involved in the development of novel therapies for classical complement-mediated disorders. The company's pipeline focuses on addressing autoimmune and neurodegenerative diseases triggered by aberrant activation of the classical complement pathway.

Overall, Gabriela C. has a strong background in assay development, immunoassays, and biomarker analysis. Gabriela has contributed to the development of diagnostics and therapeutic products in the biopharmaceutical industry.

Gabriela C. has a Bachelor of Science (B.S.) degree in Biology/Biological Sciences, General from California State University - Hayward. The duration of their education is not specified.